NCT00214110View on ClinicalTrials.gov

Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

January 31, 2005

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG

Tamoxifen

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT00214110 - Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS] | Biotech Hunter | Biotech Hunter